Average of confirmed sales; the main valuation baseline.
Lowest active listing; an asking price, not a completed sale.
Reference-price movement; low volume can make it unstable.
More sales reduce the impact of individual transactions.
Sales answer “what is it worth”; listings answer “what does an available copy cost”.
| DATE | SOURCE | Price | Change |
|---|---|---|---|
| 2026-10-15 | Sold | €2.19 | — |
| 2026-10-14 | Sold | €2.19 | — |
| 2026-10-12 | Sold | €2.19 | — |
| 2026-10-11 | Sold | €2.19 | — |
| 2026-10-10 | Sold | €2.19 | — |
| 2026-10-10 | List | €2.49 | +24.5% |
| 2026-10-09 | Sold | €2.19 | — |
| 2026-10-08 | Sold | €2.19 | — |
| 2026-10-07 | Sold | €2.19 | — |
| 2026-10-06 | Sold | €2.19 | — |
| 2026-10-05 | Sold | €2.19 | — |
| 2026-10-04 | Sold | €2.19 | — |
| 2026-10-03 | Sold | €2.19 | — |
| 2026-10-02 | Sold | €2.19 | — |
Facing a New Trial / #034
Italy: lowest · Spain: below average · EU average €2.21Choose a region above to inspect its prices and history.
DETAILED PRICES · Price History
| Condition/Grade | Price | LOW | HIGH | 7D CHG | Volume | Spark |
|---|---|---|---|---|---|---|
AggregatedRAW | €2.19 | €1.69 | €3.00 | 0.0% | >5 | |
NMRAW | €1.70 | €1.70 | €4.00 | 0.0% | >5 | |
MINTRAW | €2.19 | €1.69 | €3.00 | 0.0% | >5 |
Explore Lycanroc GX (sm2+ 034) Facing a New Trial JP #034, Normal from Facing a New Trial, with 462 price records for the EU market. Prices above are labeled by source, currency and condition. Asking prices and recorded sales are different measures, not interchangeable valuations.